33 followers
New article: Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment https://t.co/81QPCYO1It
New article: Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment https://t.co/81QPCYO1It